Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference
October 11 2007 - 9:00AM
PR Newswire (US)
DENVER, Oct. 11 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
today reported that its Wyndgate Technologies(R) ("Wyndgate"),
division will be a key exhibitor at the AABB Annual Meeting and
Transfusion Medicine Expo (TXPO). (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) The
AABB, founded in 1947, is a leader in the development of standards
for voluntary compliance in blood bank component and collection,
processing and transfusion. According to the AABB, more than 180
TXPO exhibitors will demonstrate and deliver the latest information
on the most innovative products, services and technologies for the
blood banking, transfusion and cellular therapy communities. The
annual meeting will be held at the Anaheim Convention Center in
Anaheim, California, from October 20th through October 23rd. This
will be Wyndgate's thirteenth consecutive year as a supporter,
exhibitor and sponsor of the conference. Wyndgate's well-staffed
exhibit will be in Booth 355. "With individuals from more than 88
countries attending, AABB TXPO is Wyndgate's most important annual
domestic and international conference," stated Mick Ruxin, M.D.,
Chairman and CEO of Global Med Technologies. "In addition to
presenting our own innovative technology, we are excited to be
hosting Gambro BCT, as well as a major LIS partner within our
exhibit." Dr. Ruxin continued, "We congratulate AABB on their 60th
anniversary and salute their important work in developing standards
for blood management and providing continuing education to
professionals in the blood industry." Safe Blood International,
Global Med's partner in HIV/AIDS prevention work in Africa, will be
participating in the conference. James van Hasselt, M.D., of Safe
Blood International, will be moderating "Blood Supplies and Use in
Resource Constrained Nations." Safe Blood is an emerging leader in
safeguarding the blood supply in multiple countries within
sub-Saharan Africa where contamination from infectious, blood borne
diseases, including HIV, Hepatitis B and Hepatitis C, is
widespread. Currently, several sub-Saharan sites use Wyndgate
products and services. In addition to being an exhibitor at AABB,
Wyndgate will be contributing to the event as a sponsor of the
National Blood Foundation (NBF) Golf Tournament. The tournament
aids in raising funds to support research and education initiatives
for advancing transfusion medicine, blood banking and cellular
therapies. About AABB AABB is an international, not-for-profit
association consisting of approximately 8,000 individuals and 2,000
institutions. The association and its members promote the voluntary
donation of blood. Its member facilities are responsible for
collecting virtually all of the nation's blood supply and
transfusing more than 80 percent. AABB's Annual Meeting and TXPO
gathers professionals from over 88 countries to peer network, view
the latest in blood management technology and receive information
from more than 130 educational and abstract offerings. About Global
Med Technologies, Inc. Global Med Technologies(R), Inc. is an
international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies(R) division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are also being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the Donor Doc(TM) interactive donor health history
questionnaire, SafeTrace(R) donor management system, and the
SafeTrace Tx(R) advanced transfusion management system, recently
patented, provide Vein-to-Vein(R) tracking from donor collection to
patient transfusion. For more information about Global Med's
products and services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or Investors, Paul Holm of H.L. Lanzet,
Inc., +1-212-888-4570, , for Global Med Technologies, Inc. Web
site: http://www.globalmedtech.com/ http://www.peoplemed.com/
http://www.wyndgate.com/
Copyright